Ownership history in MPM BioImpact LLC · 10 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Edgewise Therapeutics, Inc. (EWTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,655,256 | -65,485 | -3.8% | 4.70% | $41.1M | $24.82 |
| 2025 Q3 | UNCHANGED | 1,720,741 | — | 0% | 4.57% | $27.9M | $16.22 |
| 2025 Q2 | ADDED | 1,720,741 | +615,297 | +55.7% | 3.91% | $22.6M | $13.11 |
| 2025 Q1 | ADDED | 1,105,444 | +26,128 | +2.4% | 4.18% | $24.3M | $22.00 |
| 2024 Q4 | ADDED | 1,079,316 | +162,150 | +17.7% | 4.09% | $28.8M | $26.70 |
| 2024 Q3 | ADDED | 917,166 | +176,505 | +23.8% | 3.67% | $24.5M | $26.69 |
| 2024 Q2 | ADDED | 740,661 | +299,402 | +67.9% | 2.07% | $13.3M | $18.01 |
| 2024 Q1 | REDUCED | 441,259 | -271,539 | -38.1% | 1.29% | $8.0M | $18.24 |
| 2023 Q2 | ADDED | 712,798 | +408,771 | +134.5% | 1.11% | $5.5M | $7.75 |
| 2022 Q3 | INITIATED | 304,027 | — | — | 0.71% | $3.0M | $9.84 |
As of 2025 Q4 — sorted by position size